Instructions to Authors
- Page Path
-
👁 PDF
Instructions to Authors
Established in 1997
Recently revised January 1, 2026
Manuscripts for submission to the International Neurourology Journal should be prepared according to the following instructions. For issues not addressed
in these instructions, the author is referred to the ‘Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical
Journals’ (http://www.icmje.org/recommendations/).
GENERAL INFORMATION
- Aims and Scope
-
International Neurourology Journal (INJ) is a quarterly international journal that publishes high-quality research papers that provide the most significant and promising achievements in the fields of clinical neurourology and fundamental science. Specifically, fundamental science includes the most influential research papers from all fields of science and technology, revolutionizing what physicians and researchers practicing the art of neurourology worldwide know. Thus, we welcome valuable basic research articles to introduce cutting-edge translational research of fundamental sciences to clinical neurourology.
- About the Journal
-
International Neurourology Journal (INJ; pISSN 2093-4777/eISSN 2093-6931) is the official journal of The Korean Society of Functional and Reconstructive Urology (KSFRU), ESSIC (International Society for the Study of BPS), Korean Society of Urological Research, The Korean Children’s Continenc and Enuresis Society, Korean Society of Geriatric Urology and is international peer-reviewed journal. The ISO abbreviated journal name Int Neurourol J. INJ is a quarterly (last day of March, June, September, and December) international peer-review journal that publishes high-quality research papers that provide the most significant and promising achievements in the fields of clinical neurourology and fundamental science. It was launched in March 1997. The title of the first volume was Journal of the Korean Continence Society (pISSN 1738-6268). The journal title was changed to International Neurourology Journal from Volume 14 Number 1, 2010. For submission instructions, subscription, and all other information, please visit https://submit.einj.org/.
RESEARCH AND PUBLICATION ETHICS
- 1. Research Ethics
-
All manuscripts should be prepared with strict observation of the research and publication ethics guidelines presented by the Council of Science Editors (https://www.councilscienceeditors.org/), International Committee of Medical Journal Editors (ICMJE; https://www.icmje.org/), World Association of Medical Editors (WAME; https://www.wame.org/), and the Korean Association of Medical Journal Editors (KAMJE; https://www.kamje.or.kr/en/main_en).
Personal information with which a patient’s identity can be established cannot be published with any forms including texts, photos, and pedigree. When personal information of patients is critical as scientific data, it should be stated clearly that the purpose of the study and mental and physical damages that can be done during the participation to the study were sufficiently explained for and written contents were submitted by the participants or their caregivers. In a report of an experiment for human subjects, it should be stated that the study was performed according to the Helsinki Declaration (2013; https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principlesfor-medical-research-involving-human-subjects/) and approved by the Research Ethics Committee (REC) or the Institutional Review Board (IRB) of the institution where the experiment was performed. A written informed consent must be obtained from all subjects. The data for explanation such as photos should not include names, English initials, and hospital numbers of patients.
Animal experiments should also be reviewed by an appropriate committee for the care and use of animals (e.g., the Institutional Animal Care and Use Committee). Studies with pathogens requiring a high degree of biosafety should pass review by a relevant committee (e.g., the Institutional Biosafety Committee). INJ always requests the submission of copies of informed consent forms from human subjects in clinical studies or IRB approval documents.
- 2. Conflicts of Interest
-
conflict of interest may exist when an author (or the author’s institution or employer) has financial or personal relationships or affiliations that could bias the author’s decisions of the manuscript. Authors are expected to provide detailed information about all relevant financial interests and relationships or financial conflicts, particularly those present at the time the research was conducted and through publication, as well as other financial interests (such as patent applications in preparation, employment, consultancies, stock ownership, honoraria, and paid expert testimony), that represent potential future financial gain. Conflicts can occur for other reasons as well, such as personal relationships, academic competition, and intellectual passion (http://www.icmje.org/conflicts-of-interest/). All disclosures of any potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript will be disclosed by the corresponding author on behalf of each coauthor, if any, as part of the submission process. Likewise, authors without conflicts of interest will be requested to state so as part of the submission process. If authors are uncertain about what constitutes a relevant financial interest or relationship, they should contact the editorial office. Failure to include this information in the manuscript will prohibit commencement of the review process of the manuscript. For all accepted manuscripts, each author’s disclosures of conflicts of interest and relevant financial interests and affiliations and declarations of no such interests will be published. The policy requesting disclosure of conflicts of interest applies for all manuscript submissions. If an author’s disclosure of potential conflicts of interest is determined to be inaccurate or incomplete after publication, a correction will be published to rectify the original published disclosure statement. Authors are also required to report detailed information regarding all financial and material support for the research and work, including but not limited to grant support, funding sources, and provision of equipment and supplies as part of the submission process. For all accepted manuscripts, each author’s source of funding will be published.
- 3. Authorship and Contributorship
-
Authors are required to clearly state their contributions to a manuscript in the cover letter. To be listed as an author, one should have contributed substantially to all four categories established by the ICMJE: (1) conception and design, or acquisition, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Each author should be accountable for the parts of the work he or she has done. In addition, each author should be able to identify which coauthors are responsible for specific other parts of the work and should have confidence in the integrity of the contributions of any coauthors. All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors.
When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Journals generally list other members of the group in the Acknowledgments. Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship. Authors are responsible for replying to all questions asked by reviewers or editors that relate to the accuracy or integrity of any part of the work. All persons who have made a substantial contribution, but who are not eligible to be considered authors, should be named in the acknowledgments. Authors are expected to consider carefully the way authors should be listed and ordered before submitting their manuscript, and to provide a definitive list of authors with their original submission. Any addition, deletion, or rearrangement of author names in the authorship list should be made before the manuscript has been accepted— and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (1) the reason for requesting a change in the list of authors; and (2) written confirmation (by email or letter) from all authors saying that they agree with the addition, removal, or rearrangement.
Generative artificial intelligence (AI) including language models, chatbots, image creators, machine learning, or similar technologies do not qualify for authorship. The technologies listed above may be used
in enhancing readability and language accuracy in scientific writing.
The responsibility for the manuscript’s integrity ultimately rests with the human authors, and the authors employing generative AI tools in manuscript preparation are required to disclose their use in the Acknowledgments section. Such disclosure should detail the specific tools used, including the model name, version, and manufacturer, and explain the capacity in which they were employed. Should the use of AI extend beyond language enhancement, the methods and tools used must be detailed in the Materials and methods section as a formal part of the research design.
- 4. Readership
-
INJ is primarily for clinicians and researchers who care patients with urologic disease including lower urinary tract dysfunction. They are able to obtain tailored information to adopt for their research and practice. Its readership can be expanded to other positions: (1) Researchers can get the recent topics of clinical and basic research in lower urinary tract disease and neurourology field and detailed research methods; (2) Clinicians in the field can get the new information and recent development for care of patients; (3) Medical teacher can access and adopt a variety of data in medical education; (4) Allied health professionals including nurses are able to get the recent information for care of patients with urologic disease including lower urinary tract dysfunction; (5) Medical health students can understand the recent trends of the field and interesting cases for their work; (6) Policy makers are able to reflect the results of the articles to the nation-wide health care policies for patients with urologic disease including lower urinary tract dysfunction; (7) The public, especially family of patients with spine and spinal cord diseases are able to read the advancement in their family’s diseases so that they have a better knowledge on the diseases and a confidence in the clinicians’ devotion to their family.
- 5. Redundant Publication and Plagiarism
-
A redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s).” The characteristics of reports that are substantially similar include the following: (1) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant publication),” (2) “the subject or study populations are often the same or similar,” (3) “the methodology is typically identical or nearly so,” and (4) “the results and their interpretation generally vary little, if at all.”
When submitting a manuscript, authors should include a letter informing the Editor of any potential overlap with other already published material or material being evaluated for publication and should also state how the manuscript submitted to INJ differs substantially from this other material. If all or part of the patient population was previously reported, this should be mentioned in the Materials and Methods, with citation of the appropriate reference(s).
The editorial committee checks similarity by using the iThenticate (http://www.ithenticate.com/) program for all submitted articles to prevent plagiarism. The editorial committee rejects any article suspected of plagiarism and asks the author to check whether it is plagiarized and resubmit as appropriate.
- 6. Obligation to Register Clinical Trials
-
A clinical trial defined as “any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome,” and clinical trials should be registered in a primary registry prior to publication.
INJ accepts the registration in any of the primary registries that participate in the International Clinical Trials Registry Platform (ICTRP) (https://www.who.int/clinical-trials-registry-platform), as well as https://www.anzctr.org.au/, www.clinicaltrials.gov, www.umin.ac.jp/ctr/index/htm, and www.trialregister.nl. The clinical trial registration number shall be published at the end of the abstract.
- 7. Process for Identifying and Dealing With Allegations of Research Misconduct
-
When the journal faces suspected cases of research and publicationmisconduct, such as a redundant (duplicate) publication, plagiarism,fabricated data, changes in authorship, undisclosed conflicts of interest,an ethical problem discovered with the submitted manuscript, a reviewerwho has appropriated an author’s idea or data, complaintsagainst editors, and other issues, the resolving process will follow theflowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The editorial committeewill discuss the suspected cases and reach a decision. We will not hesitateto publish errata, corrigenda, clarifications, retractions, and apologieswhen needed.
INJ adheres to the research and publication ethics policies outlinedin the International Standards for Editors and Authors (https://publicationethics.org/resources/resources-and-further-reading/internationalstandards-editors-and-authors) and the Recommendations for theConduct, Reporting, Editing, and Publication of Scholarly work inMedical Journals (https://www.icmje.org/recommendations/). Anystudies involving human subjects must comply with the principles ofthe World Medical Association Declaration of Helsinki. Clinical researchshould be approved by the Institutional Review Board and obtainpatient consent. A patient’s personal information generally cannotbe published in any form. However, if it is absolutely necessary to use apatient’s personal information, the consent of the patient or his/herguardian will be needed before publication. Animal studies should beperformed in compliance with all relevant guidelines, observing thestandards described in the NIH Guide for the Care and Use of LaboratoryAnimals. Cases that require editorial expressions of concern or retractionshall follow the Committee of Publication Ethics (COPE)flowcharts available from: http://publicationethics.org/resources/flowcharts.If a correction is needed, it will follow the ICMJE Recommendationfor Corrections, Retractions, Republications and Version Controlavailable from: http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/corrections-and-version-control.htmlas follows:
Honest errors are a part of science and publishing and require publication of a correction when they are detected. Corrections are needed for errors of fact. The minimum standards are as follows: First, the journal shall publish a correction notice as soon as possible, detailing changes from and citing the original publication on both an electronic and numbered print page that is included in an electronic or a print Table of Contents to ensure proper indexing; second, the journal shall post a new article version with details of the changes from the original version and the date(s) on which the changes were made through CrossMark; third, the journal shall archive all prior versions of the article, and this archive can be directly accessible to readers; and fourth, previous electronic versions shall prominently note that there are more recent versions of the article via CrossMark.
- 8. Handling Complaints and Appeals
-
The policies of the journal are primarily aimed at protecting the authors,reviewers, editors, and the publisher of the journal. If not describedbelow, the process of handling complaints and appeals followsthe guidelines of the Committee of Publication Ethics available from:https://publicationethics.org/appeals
- Who complains or makes an appeal?
Submitters, authors, reviewers, and readers may register complaintsand appeals in a variety of cases as follows: falsification, fabrication,plagiarism, duplicate publication, authorship dispute, conflict of interest,ethical treatment of animals, informed consent, bias or unfair/inappropriatecompetitive acts, copyright, stolen data, defamation, and legalproblems. If any individuals or institutions want to inform the journalabout a relevant case, they can send a letter to the editor through https://einj.org/. For complaints or appeals, concrete data with answersto all factual questions (who, when, where, what, how, why)should be provided.
- Who is responsible for resolving and handling complaints and appeals?
The editor, editorial board, or editorial office is responsible for them.
- What may be the consequences of resolution?
The consequences depend on the type or degree of misconduct. Theconsequence of resolution will follow the guidelines of the COPE(http://publicationethics.org/resources/flowcharts).The editorial committee of INJ will discuss suspected cases and reach adecision. INJ will not hesitate to publish errata, corrigenda, clarifications,retractions, and apologies when needed.
- 9. Postpublication Discussions and Corrections
-
Postpublication discussions can be conducted through letters to theeditor. If any readers have a concern about any articles published, theycan submit a letter to the editor about the issue. If any errors or mistakesin the article are found, the article can be corrected through anerratum, corrigendum, or retraction.
- 10. Policies on Data Sharing and Reproducibility
-
Authors have the option to share with readers the datasets used in theirresearch. Authors wishing to do so may deposit their data in a publiclyaccessible repository and include a link to the DOI within the text ofthe manuscript, as well as in an optional category in the StructuredDisclosures section. For example, “Data sharing: The data analyzed forthis study have been deposited in Harvard Dataverse (https://dataverse.harvard.edu) and are available at DOI.”
SUBMISSION OF MANUSCRIPTS
- 1. General Guideline
-
Authors are requested to submit their papers electronically by usingonline manuscript submission.
The corresponding author is responsible for the submission and revisionof the manuscript. An ID is required for processing and can begenerated on the homepage.
All authors should sign the Submission Agreement form to certifythat the contents of the manuscript have not been published and arenot being considered for publication elsewhere. If any research granthas been given by any private company or group, this informationshould be described on the form. All authors must sign their own signatures.
The form can be downloaded at the homepage of INJ (https://submit.einj.org/file/INJ_Copyright%20transfer_Conflict%20of%20Interest_form.pdf), and should be submitted at the time of paper submission.
Regarding author information, the list of authors in the manuscriptshould include only those who were directly involved in the process of thework. Authors can refer to the guideline by Harvard University in 1999 tofind details on authorship (https://hms. harvard.edu/sites/default/files/assets/Sites/Ombuds/files/AUTHORSHIP%20GUIDELINES.pdf).
The decision of whether to publish a submitted manuscript will bemade solely by the editorial committee.
Professional editing in English is recommended for nonnativespeakers. The editorial office may request English editing. For acceptedmanuscripts, we may provide copy editing free of charge.
All published papers become the permanent property of The KoreanSociety of Functional and Reconstructive Urology (KSFRU). The copyrightsof all published materials are owned by KSFRU. Permission mustbe obtained from KSFRU for any commercial use of materials. Everyauthor must sign the copyright transfer agreement forms.
All manuscript pages are to be numbered consecutively, beginningwith the abstract as page 1. Neither the authors’ names nor their affiliationsshould appear on the manuscript pages. The use of acronyms andabbreviations is discouraged and should be kept to a minimum. Whenused, they are to be defined where first used, followed by the acronymor abbreviation in parentheses. Abbreviations are not allowed in the title.
The names of manufacturers of equipment and nongeneric drugsshould be given. When quoting from other sources, give a referencenumber in bracket after the author’s name or at the end of the quotation.
- 2. Reporting Guidelines for Specific Study Designs
-
For specific study designs, such as randomized control studies, studiesof diagnostic accuracy, meta-analyses, observational studies, and nonrandomizedstudies, authors are encouraged to consult the reportingguidelines relevant to their specific research design. A good source ofreporting guidelines is the EQUATOR Network (https://www.equatornetwork.org) and NLM (https://www.nlm.nih.gov/services/research_report_guide.html).
MANUSCRIPT PREPARATION
- Authors should refer to “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (http://www.icmje.org/about-icmje/faqs/icmje-recommendations/).
- 1. Formatting by Manuscript Type
-
Original Articles should be composed of no more than 3,000 words,excluding the references, tables, and figures. No more than 35 referencescan be cited. It should be organized in the following order: (1) titlepage, (2) abstract and keywords, (3) introduction, (4) materials (orsubjects) and methods, (5) results, (6) discussion, (7) conflict of interest,(8) funding, (9) acknowledgments (if necessary), (10) references,(11) tables, (12) figures, and (15) supplementary materials.
Review Articles are reserved for important subjects relevant to theneurourology field that is selected by the editorial committee. Authorsare invited based on articles published in INJ and other journals. Thelength of the manuscript and the number of references should not exceed3,500 words and 100, respectively. The decision to publish themanuscript is made after review by the editorial committee. The manuscriptformat may vary in review articles.
Systematic Reviews are critical assessments of the literature and datasources pertaining to clinical topics, emphasizing factors such as thecause, diagnosis, prognosis, therapies, and prevention.
Systematic Reviews without a meta-analysis are published as reviews;those with a meta-analysis are published as Original Articles (see Metaanalyses).Meta-analyses are systematic, critical assessments of the literatureand data sources pertaining to clinical topics, emphasizing factors suchas the cause, diagnosis, prognosis, therapies, and prevention, that includea statistical technique for quantitatively combining the results ofmultiple studies that measure the same outcome into a single pooled orsummary estimate. The requirements for the format of the abstract andthe main text follow those for Original Articles.
Editorial are solicited by the editor and should not be submitted withoutprior invitation. Editorials are invited perspectives on an area of infectiousdisease science, dealing with fields of research, current medicalinterests, fresh insights and debates.
Letters to the Editor discuss a recent article in this journal andshould be submitted within 4 weeks of the article’s publication in print.
It is not usually peer-reviewed but accepted on the basis of pertinenceand scientific quality. The journal may invite replies from the authorsof the original publication or pass on the correspondence to these authors.
Upon review and approval by the editor, Letters to the Editorand relevant replies will be published together.
The detailed formatting recommendations for each type are shownin the table below.
- Summary Table of Manuscript Types
-
| Type |
Abstract |
Main
text |
Max.
tables |
Max.
figures |
Max.
references |
Max.
words |
Max.
keywords |
Format |
Max.
words |
| Review Article |
300 |
6 |
Unstructured |
3,500 |
5 |
5 |
100 |
| Systematic Review |
300 |
6 |
Unstructured |
3,500 |
5 |
5 |
100 |
| Original Article |
300 |
6 |
Structured |
3,000 |
5 |
5 |
35 |
Systematic Review
& Meta-analysis |
300 |
6 |
Structured |
3,000 |
5 |
5 |
35 |
| Editorial |
× |
× |
× |
1,000 |
× |
× |
10 |
| Letter to the Editor |
× |
× |
× |
500 |
× |
× |
10 |
Note: Exceptions may be made to the above specifications according to the decision of the editorial committee.
- 2. Title Page
-
The title page contains the article title, and full names of all authorswith their institutional affiliations both. The type of manuscript (originalarticle, review article, editorial, letter to the editor) should also beindicated. If the work includes multiple authors with different affiliations,the institution where the research was mainly conducted shouldbe spelled out first, and then be followed by footnotes in superscriptArabic numerals beside the authors’ names to describe their affiliationsin the consecutive order of the numbers.
The title page also contains the postal address and email address ofthe corresponding author at the bottom of the page, as well as informationon any previous presentation of the manuscript in conferences andfunding resources, if necessary.
The title should be concrete and not exceed 20 words, and the runningtitle should not exceed 50 characters, including spaces.
- 3. Abstract
-
Abstracts for articles presenting clinical or laboratory research shouldcontain the following sections: purpose, materials and methods, results,and conclusions. However, these sections are not necessary for othertypes of studies. An abstract should include brief descriptions of thepurpose, materials and methods, results, and conclusions, as well as adetailed description of the data. An abstract containing 300 words orless is required for original articles and review articles. Abstracts can berevised by the decision of the editorial committee, and some sentencescan be modified as a result of revision.
A list of key words, with maximum of 6 items, should be included atthe end of the abstract. The selection of key words should be based onMedical Subject Heading (MeSH) of Index Medicus and the website(http://www.nlm.nih.gov/mesh/MBrowser.html), and each keywordshould begin with a capital letter and be separated by a semicolon.
- 4. Introduction
-
The introduction should address the purpose of the article concisely,and include a presentation of the background relevant to the purposeof the paper. A more detailed review of the literature should be addressedin the discussion section.
- 5. Materials and Methods
The article should record the research plans, objectives, and methodsin order, as well as the data analysis strategies and methods implementedto control bias. Sufficient details should be furnished for the readerto understand the method(s) without reference to another work describedin the study.
When reporting experiments with human subjects, the authors mustdocument the approval received from the local IRB. When reportingexperiments with animal subjects, the authors should indicate whetherthe handling of the animals was supervised by the research board ofthe affiliated institution or a similar entity. The IRB approval numbermust be noted.
Photographs disclosing patients must be accompanied by a signed release form from the patient or the patient’s family permitting publication.
Authors should ensure correct use of the terms sex (when reportingbiological factors) and gender (identity, psychosocial, or cultural factors),and, unless inappropriate, report the sex and/or gender of studyparticipants, the sex of animals or cells, and describe the methods usedto determine sex and gender. If the study was done involving an exclusivepopulation, for example in only one sex, authors should justifywhy, except in obvious cases (e.g., prostate cancer). Authors should definehow they determined race or ethnicity and justify their relevance.
- 6. Results
-
The authors should describe clearly and logically their significant findingsof observations or results corresponding to the purpose of thestudy, following the order in the methods. The authors should avoidoverlapping descriptions by figures or tables and by main text, describingimportant results only.
It should be clear which statistical test is associated with each p-valuereported. Rarely used statistical techniques should be described. Mediansand percentiles (such as quartiles) are preferred over means andstandard deviations (or standard errors) when analyzing asymmetricdata, especially when nonparametric statistics are calculated. Fractions(e.g., 5/10) should accompany percentages. In randomized clinical trials,consider reporting separate analyses with confounding variablesincluded. If sample sizes differ between groups when patients are randomized,reasons should be provided.
Tables and graphs should be used to show numerical data, while descriptivesentences should be reserved for only important data. Demographicdata of study subjects, such as age and the sex/gender distribution,should not be mentioned in this section. The repetitive enumerationof findings shown in tables and graphs should be avoided. Thepast tense should be used.
- 7. Discussion
-
Important or new findings from the results of the study should be emphasizedand the consequent conclusions are described, while repetitionof the contents in the introduction and the results should beavoided. The authors are needed to describe the significance and limitationsof the study and directions for the further studies, comparingwith the results of the other related studies.
- 8. References
-
All references should be numbered consecutively in the order in whichthey are first mentioned in the text. In using in-text reference citation,each reference should be cited in square brackets as [1], [1,2], or [1-3].The reference format should conform to the Vancouver form (N Engl JMed 1997;336:309-15; https://www.nejm.org/doi/full/10.1056/nejm199701233360422).
Use the style of the examples below, which are based on the formatsused by the U.S. National Library of Medicine (NLM) in Index Medicus.The titles of journals should be abbreviated according to the styleused in Index Medicus. Authors should consult the List of Journals Indexedin Index Medicus, published annually as a separate publicationby the library and as a list in the January issue of Index Medicus. Thelist can also be obtained through the library’s web site: https://www.nlm.nih.gov/bsd/aim.html.
Avoid using abstracts as references. References to papers acceptedbut not yet published should be designated as “in press” or “forthcoming”;authors should obtain written permission to cite such papers aswell as verification that they have been accepted for publication. Informationfrom manuscripts submitted but not accepted should be citedin the text as “unpublished observations” with written permission fromthe source.
Avoid citing a “personal communication” unless it provides essentialinformation not available from a public source, in which case the nameof the person and date of communication should be cited in parenthesesin the text. For scientific articles, authors should obtain written permissionand confirmation of accuracy from the source of a personalcommunication.
The references must be verified by the author(s) against the originaldocuments.
The “Uniform Requirements” style (the Vancouver style) is basedlargely on an ANSI standard style adapted by the NLM for its databases.
- 1) Articles in Journals
- (1) Standard journal article List the first six authors followed by et al.
- - Lee KS, Han DH, Lee YS, Choo MS, Yoo TK, Park HJ, et al. Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: an 8-week prospective study. J Korean Med Sci 2010;25:117-22.
- - Djavan B. Nickel JC, de la Rosette J, Abrams P. The urologist view of BPH progression: results of an international survey. Eur Urol 2002;41:490-6.
- (2) Other samples
- - Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994;102 Suppl 1:275-82.
- - Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996;23(1 Suppl 2):89-97.
- - Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995; 32(Pt 3):303-6.
- - Poole GH, Mills SM. One hundred consecutive cases of flap lacerations of the leg in ageing patients. N Z Med J 1994;107(986 Pt 1):377-8.
- - Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop 1995;(320):110-4.
- - Enzensberger W, Fischer PA. Metronome in Parkinson’s disease [letter]. Lancet 1996;347:1337.
- - Clement J, De Bock R. Hematological complications of hantavirus nephropathy (HVN) [abstract]. Kidney Int 1992;42:1285.
- 2) Books
- (1) Personal author(s)
- - Partin AW, Peters CA, Kavoussi LR, Dmochowski RR, Wein AJ, editors.
Campbell Walsh Wein urology. 12th ed. Amsterdam (Netherlands):
Elsevier, Inc.; 2020.
- (2) Editor(s), compiler(s) as author
- - Norman IJ, Redfern SJ, editors. Mental health care for elderly people.
New York (NY): Churchill Livingstone; 1996.
- (3) Organization as author and publisher
- - Institute of Medicine (US). Looking at the future of the Medicaid
program. Washington (DC): The Institute; 1992.
- (4) Chapter in a book
- - Klein EA, Platz EA, Thompson IM, Epidemiology, etiology, and prevention
of prostate cancer. In: Wein AJ, Kavoussi LR, Novick AC,
Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed.
Philadelphia (PA): Saunders; 2007. p. 2854-73.
- 3) Conference proceedings
- - Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam (Netherlands): Elsevier, Inc.; 1996.
- 4) Conference paper
- - Bengtsson S, Solheim BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland. Amsterdam (Netherlands): North-Holland; 1992. p. 1561-5.
- 5) Scientific or technical report
- - Smith P, Golladay K. Payment for durable medical equipment billed during skilled nursing facility stays. Final report. Dallas (TX): Dept. of Health and Human Services (US), Office of Evaluation and Inspections; 1994 Oct. Report No.: HHSIGOEI69200860.
- 6) Dissertation
- - Kaplan SJ. Post-hospital home health care: the elderly’s access and utilization [dissertation]. St. Louis (MO): Washington Univ.; 1995.
- 7) Patent
- - Larsen CE, Trip R, Johnson CR, inventors; Novoste Corporation, assignee. Methods for procedures related to the electrophysiology of the heart. US patent 5,529,067. 1995 Jun 25.
- 8) Newspaper article
- - Lee G. Hospitalizations tied to ozone pollution: study estimates 50,000 admissions annually. The Washington Post 1996 Jun 21;Sect. A:3 (col. 5).
- 9) In press
- - Leshner AI. Molecular mechanisms of cocaine addiction. N Engl J Med Forthcoming 1997.
- 10) Websites
- 9. Tables
- • Tables should be created using the table formatting and editing feature of Microsoft Word and should not be provided in noneditable image format.
- • The title of the table must be noted. Tables cannot be submitted in a picture format.
- • Each table should be inserted on a separate page, with the table number, table title and legend above the table.
- • Tables should be concise and not duplicate information found in figures.
- • The significance of results should be indicated by an appropriate statistical analysis.
- • Unnecessary longitudinal lines should not be drawn. Horizontal lines should be used as sparingly as possible.
- • All symbols and abbreviations should be described below the table.
- • Table footnotes should be indicated with superscript alphabet in sequence: a), b), c), …, etc.
- • All units of measurement and concentrations should be designated.
- 10. Figures
- • Figures should have resolution of 300 dpi or above and should be submitted individually—namely, if Figure 1 is divided into A, B, C, and D, do not combine them into one, but submit each of them separately. The preferred file formats for figures are JPG (JPEG) or TIF (TIFF).
- • Figure files should be named according to the figure name (example: Fig. 1A.tif). If the quality of the photographs is considered inappropriate for printing, the journal may request resubmission.
- • Authors should submit figures in black and white if they want them to be printed in black and white. Authors are responsible for any additional costs of producing color figures, as determined by the editorial committee.
- • Line art should have resolution of 1,200 dpi or more in JPG or TIF format.
- • All symbols and abbreviations should be described below the figure.
- • Using AI technologies in creating or altering figures, images, and artwork are discouraged unless such use is part of the research design or methods. If authors deem it necessary to use AI tools for these purposes, they must provide a clear description of the content generated, including the name of the tool, version, and manufacturer. This information should accompany the submission. In line with our commitment to maintain the highest ethical standards, the editorial board of INJ discourages the submission or publication of materials solely created by AI technologies without the necessary human oversight.
The editorial board of INJ hold authors accountable for the integrity of the content generated by these AI models and tools, reiterating that authorship brings with it responsibility for the accuracy, integrity, and originality of the work.
- 11. Units of Measurement
- • Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter or their decimal multiples).
- • Temperatures should be given in degrees Celsius (°C). Blood pressure should be given in millimeters of mercury (mmHg).
- • All hematologic and clinical chemistry measurements should be reported in the metric system in terms of the International System of Units (SI). Editors may request that alternative or non-SI units be added by the authors before publication.
- 12. Abbreviations and Symbols
-
Use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
- 13. Author Checklist
- • Before submitting a manuscript, authors should double-check all requirements noted in the agreement form regarding the registration and copyrights of their manuscript. A manuscript that does not fit the author instructions of the journal regarding format and references will be returned to the authors for further correction.
- • The author checklist should be prepared, signed by the corresponding author, submitted with the manuscript, and then registered online. Relevant forms can be downloaded from the manuscript submission site.
PEER REVIEW AND PUBLICATION PROCESS
-
INJ has an online submission and peer review system at https://einj.org/.
INJ reviews all manuscripts received. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript meets these 2 criteria, it is dispatched to 3 investigators in
the field with relevant knowledge.
INJ adopts double blind review, which means that the reviewers and authors cannot identify each other’s information. The authors’ names and affiliations are removed during peer review. Assuming the manuscript is sent to reviewers, INJ waits to receive opinions from at least 2 reviewers. In addition, if deemed necessary, a review of statistics may be requested. The acceptance criteria for all papers are based on the quality and originality of the research and its scientific significance. Acceptance of the manuscript is decided based on the critiques and recommended decision of the reviewers.
An initial decision will normally be made within 4 weeks of receipt of a manuscript, and the reviewers’ comments are sent to the corresponding author by email. The corresponding author must indicate the alterations that have been made in response to the reviewers’ comments item by item. Failure to resubmit the revised manuscript within 4 weeks of the editorial decision is regarded as a withdrawal. A final decision on acceptance/rejection for publication is forwarded to the corresponding author from the editor.
All manuscripts from editors, employees, or members of the editorial board are processed same to other unsolicited manuscripts. During the review process, submitters will not engage in the decision process. Editors
will not handle their own manuscripts although they are commissioned ones.
The editorial board of INJ neither guarantee the acceptance without review nor very short peer review times for unsolicited manuscripts.
Commissioned manuscripts also were reviewed before publication.
- 1. Registration for Submission
-
Any manuscript that has many errors or does not follow the guideline
for submissions will be returned to the author without review. Any
manuscript registered is given a registration number, which will be
emailed to the corresponding author. Once the editorial committee requests
an author to revise his or her manuscript, the author should resubmit
the revised manuscript using our online submission system.
- 2. Review
-
The manuscript will be reviewed by two or three reviewers (one reviewer
and one editor) blind to the name and affiliation of the authors.
The review process is limited to 3 times; a decision for revision at the
third review means the manuscript is no longer eligible for publication.
- 3. Revision by Authors
-
Upon the Editorial Committee’s request, authors should revise and resubmit
the revised manuscript accompanied by a cover letter indicating
clearly what alterations have been made in response to the reviewer’s
comments and stating satisfactory reasons for noncompliance with
any of the recommendations of the editors. No reply within 45 days after
the request for revision will be assumed as a withdrawal of the manuscript
and the review process will be terminated. In this case, a new
submission is required if authors desire further review of their manuscript
by the editorial committee. The review process will require 3
months on average.
- 4. Conclusion of Review
-
Once the manuscript is accepted for publication in INJ, a certification
of publication stating that the manuscript will be published can be issued
on demand by the author(s).
- 5. Printing
-
The authors should proofread and edit their accepted manuscript carefully
before printing, and can still request additional corrections at this
stage. The editorial committee makes the final edits and decides
whether to publish the manuscript and the order in which the manuscript
is published.
- 6. Proofreading and Article Processing Charge
-
Once a manuscript is accepted for publication by the journal, it will be sent to press, and page proofs will be sent to authors. Authors must respond to the page proofs as soon as possible after making necessary corrections of misspellings and the locations of photographs, figures or tables.
At this stage, authors can make corrections for only typographic errors, and are not allowed to make any authorial alterations or substantive changes to the text. Proofs must be returned to the press within 48 hours of receipt. No response from the authors within this time frame will lead the publication of the proof without corrections, and the editorial board will not be responsible for any mistakes or errors occurring in this process.
There is no APC (article processing charge), also known as a publication fee (including a submission fee) for accepted articles.
COPYRIGHT AND LICENSING
- 1. Copyright Policy
-
All published papers become the permanent property of KSFRU. Copyrights of all published materials are owned by KSFRU. Permission must be obtained from KSFRU for any commercial use of materials. Every author must sign the copyright transfer agreement forms.
- 2. Open Access
-
All articles published in INJ will be immediately and permanently free for everyone to read and download. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
- 3. Repository Policy
-
According to the deposit policy (self-archiving policy) of Sherpa/Romeo (http://www.sherpa.ac.uk/), authors cannot archive preprints (i.e., prerefereeing), but they can archive postprints (i.e., the final draft postrefereeing). Authors can archive the publisher’s version/ PDF.
Authors are advised to refrain from posting manuscripts during prepublishing in institutional repositories, or websites, before and during the submission process. They may, however, post the PDF version of the publisher’s final format without embargo after publication. Authors should always clearly attribute INJ as the original source of publication and provide accurate citation details when posting, reusing, or distributing published open access articles elsewhere. The URL/DOI of the published article in addition to the version of record should be deposited when posting an author’s published article to any repository.
-
Editor-in-Chief: Khae Hawn Kim
Editorial Office
Department of Urology, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongnogu, Seoul 03181, Korea
Tel: +82-2-2001-2237, Fax: +82-2-2001-2247, E-mail: support@einj.org
